Latest filing published 15 Jun 2023 for Nutex Health, Inc., €20k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mitchell Creem: trading record in brief
This profile gathers the share dealings of Mitchell Creem in Nutex Health, Inc., where the filings describe the role as board member. In total, 5 filings cover trades dated from 12 August 2020 to 14 June 2023.
Every open-market trade on record is a purchase: 2 purchases worth €538.4M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants. Since January 2023: 1 purchase and no sales on the market.
The record was last updated on 15 June 2023 with an open-market purchase (€20k) in Nutex Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 28 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mitchell Creem
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$0.428311.2% of flowCommon StockSEC:0001486189-23-000005:0Canonical exit: 12 Sept 2023 (T+90)
- 21,208 shares@ US$3.8944.4% of flowRestricted StockSEC:0001486189-22-000021:0
- 21,208 shares@ US$3.8979.8% of flowRestricted Stock AwardSEC:0001486189-22-000012:0
3 of 3 declarations